- Sanofi: Nasacort first nasal corticosteroid available without a prescription
- FDA approves Plan B One-Step OTC switch
- Roxane Labs' generic prostate drug gets tentative approval from FDA
- USPLabs agrees to recall and destroy dietary supplement following FDA actions
- Senate passes Drug Quality and Security Act
BALTIMORE — The Food and Drug Administration has approved a generic drug for insomnia made by Lupin, the drug maker said.
The FDA approved zolpidem tartrate extended-release tablets in the 6.25-mg and 12.5-mg strengths, a generic version of Sanofi's Ambien CR.
The branded version of the drug had sales of $366 million during the 12-month period ended in March, according to IMS Health.